BROOKE RANEY: Open Payments
NPI 1033612585 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 59 payments from 10 companies in 2025. Trend: 2023 $1,200 · 2024 $1,051 · 2025 $1,009
Food & beverage: $926Education: $83
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 23 | $321 |
| Janssen Biotech, Inc. | 15 | $216 |
| UCB, Inc. | 5 | $172 |
| Organon LLC | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Lilly USA, LLC | 3 | $58 |
| GENZYME CORPORATION | 2 | $41 |
| ABBVIE INC. | 2 | $38 |
| Amgen Inc. | 1 | $20 |
| Almirall LLC | 1 | $18 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, COSENTYX, DUPIXENT, SKYRIZI, EBGLYSS, VTAMA.
Industry payments across TX — which companies pay providers there.
